Prostate Cancer New Reference: Enzalutamide in Recurrent Prostate Cancer Ulas D. Bayraktar, MD 2023-11-20
Prostate Cancer New Indication: Talazoparib and Enzalutamide in Metastatic CRPC Ulas D. Bayraktar, MD 2023-06-24
Prostate Cancer New Protocol: Abiraterone Acetate With or Without Cabazitaxel in the Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC) Ulas D. Bayraktar, MD 2023-06-07
Prostate Cancer New Protocol: Niraparib and abiraterone acetate plus prednisone for BRCA-mutated metastatic castration-resistant prostate cancer Ulas D. Bayraktar, MD 2023-06-06
Prostate Cancer New Indication: Darolutamide in Metastatic Hormone-Sensitive Prostate Cancer Ulas D. Bayraktar, MD 2022-05-20
